» Articles » PMID: 28853896

The Weak Link: Optimization of the Ligand-Nanoparticle Interface To Enhance Cancer Cell Targeting by Polymer Micelles

Overview
Journal Nano Lett
Specialty Biotechnology
Date 2017 Aug 31
PMID 28853896
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Many promising targeting ligands are hydrophobic peptides, and these ligands often show limited accessibility to receptors, resulting in suboptimal targeting. A systematic study to elucidate the rules for the design of linkers that optimize their presentation on nanoparticles has not been carried out to date. In this study, we recombinantly synthesized an elastin-like polypeptide diblock copolymer (ELP) that self-assembles into monodisperse micelles. AHNP and EC1, two hydrophobic ErbB2-targeted peptide ligands, were incorporated at the C-terminus of the ELP with an intervening peptide linker. We tested more than 20 designs of peptide linkers, where the linker could be precisely engineered at the gene level to systematically investigate the molecular parameters-sequence, length, and charge-of the peptide linker that optimally assist ligands in targeting the ErbB2 receptor on cancer cells. We found that peptide linkers with a minimal length of 12 hydrophilic amino acids and an overall cationic charge-and that impart a zeta potential of the micelle that is close to neutral-were necessary to enhance the uptake of peptide-modified ELP micelles by cancer cells that overexpress the ErbB2 receptor. This work advances our understanding of the optimal presentation of hydrophobic ligands by nanoparticles and suggests design rules for peptide linkers for targeted delivery by polymer micelles, an emerging class of nanoparticle carriers for drugs and imaging agents.

Citing Articles

Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy.

Hong J, Sim D, Lee B, Sarangthem V, Park R J Nanobiotechnology. 2024; 22(1):293.

PMID: 38802812 PMC: 11131307. DOI: 10.1186/s12951-024-02559-5.


The construction of elastin-like polypeptides and their applications in drug delivery system and tissue repair.

Guo Y, Liu S, Jing D, Liu N, Luo X J Nanobiotechnology. 2023; 21(1):418.

PMID: 37951928 PMC: 10638729. DOI: 10.1186/s12951-023-02184-8.


Concentration-Independent Multivalent Targeting of Cancer Cells by Genetically Encoded Core-Crosslinked Elastin/Resilin-like Polypeptide Micelles.

Weber P, Dzuricky M, Min J, Jenkins I, Chilkoti A Biomacromolecules. 2021; 22(10):4347-4356.

PMID: 34477380 PMC: 9339257. DOI: 10.1021/acs.biomac.1c00897.


Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug.

Costa S, Mozhdehi D, Dzuricky M, Isaacs F, Brustad E, Chilkoti A Nano Lett. 2018; 19(1):247-254.

PMID: 30540482 PMC: 6465085. DOI: 10.1021/acs.nanolett.8b03837.


Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing.

He H, Guo C, Wang J, Korzun W, Wang X, Ghosh S Nano Lett. 2018; 18(10):6164-6174.

PMID: 30207473 PMC: 6292712. DOI: 10.1021/acs.nanolett.8b01892.

References
1.
Meyer D, Chilkoti A . Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat Biotechnol. 1999; 17(11):1112-5. DOI: 10.1038/15100. View

2.
Park B, Zhang H, Wu C, Berezov A, Zhang X, Dua R . Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo. Nat Biotechnol. 2000; 18(2):194-8. DOI: 10.1038/72651. View

3.
Yu D, Hung M . Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene. 2001; 19(53):6115-21. DOI: 10.1038/sj.onc.1203972. View

4.
Kataoka K, Harada A, Nagasaki Y . Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001; 47(1):113-31. DOI: 10.1016/s0169-409x(00)00124-1. View

5.
Berezov A, Zhang H, Greene M, Murali R . Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis. J Med Chem. 2001; 44(16):2565-74. DOI: 10.1021/jm000527m. View